Alnylam Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 2 095
EBIT TTM (mln): -187
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Rok finansowy 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 4 6 27 51 96 101 100 83 67 47 51 41 47 90 75 220 493 844 1,037 1,828 2,248
Przychód Δ r/r 0.0% inf% 2330.7% 33.6% 371.1% 89.0% 88.9% 4.5% -0.5% -17.3% -19.4% -29.3% 7.2% -18.7% 14.8% 90.7% -16.7% 193.4% 124.3% 71.3% 22.9% 76.2% 23.0%
Marża brutto 0.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 97.6% 88.6% 84.2% 83.4% 83.7% 83.0% 85.6%
EBIT (mln) -4 -25 -32 -43 -40 -93 -28 -48 -44 -55 -129 -93 -405 -296 -425 -500 -815 -939 -828 -709 -785 -282 -177
EBIT Δ r/r 0.0% 493.5% 28.8% 34.7% -9.1% 135.9% -70.1% 72.8% -8.4% 24.4% 136.2% -28.2% 335.7% -26.9% 43.4% 17.8% 62.9% 15.3% -11.8% -14.5% 10.8% -64.1% -37.3%
EBIT (%) 0.0% -14236.9% -754.2% -760.5% -146.7% -183.1% -28.9% -47.9% -44.1% -66.2% -194.0% -197.0% -801.0% -720.3% -900.3% -556.2% -1087.6% -427.5% -168.1% -83.9% -75.7% -15.4% -7.9%
Koszty finansowe (mln) 0 0 -1 -1 -1 -1 1 5 2 1 1 1 3 6 8 12 29 0 84 143 156 121 142
EBITDA (mln) -4 -15 -30 -40 -35 -89 -23 -48 -50 -54 -16 -93 37 -296 -425 -500 -835 -939 -771 -709 -894 -228 -179
EBITDA(%) 0.0% -8507.4% -691.6% -705.6% -131.6% -174.5% -23.6% -47.4% -50.5% -65.6% -23.3% -197.0% 72.3% -720.3% -900.3% -556.2% -1115.0% -427.5% -156.5% -84.0% -86.2% -12.5% -8.0%
Podatek (mln) -0 5 0 -1 -5 5 1 1 1 -6 -11 -3 -40 -25 -23 -26 1 1 3 1 4 7 99
Zysk Netto (mln) -4 -25 -33 -43 -35 -85 -26 -48 -44 -58 -106 -89 -360 -290 -410 -491 -761 -886 -858 -853 -1,131 -440 -278
Zysk netto Δ r/r 0.0% 505.2% 30.4% 31.4% -19.4% 147.0% -69.3% 81.3% -8.6% 32.5% 83.9% -15.8% 303.9% -19.5% 41.4% 19.7% 55.1% 16.4% -3.1% -0.6% 32.6% -61.1% -36.8%
Zysk netto (%) 0.0% -14223.3% -763.3% -750.8% -128.5% -167.9% -27.3% -47.3% -43.5% -69.7% -158.9% -189.2% -712.8% -705.8% -869.6% -545.9% -1016.6% -403.2% -174.1% -101.0% -109.0% -24.1% -12.4%
EPS -12.48 -26.56 -2.75 -1.96 -1.09 -2.21 -0.64 -1.14 -1.04 -1.36 -2.11 -1.45 -4.85 -3.45 -4.79 -5.42 -7.57 -8.11 -7.46 -7.2 -9.3 -3.52 -2.16
EPS (rozwodnione) -12.48 -26.56 -2.75 -1.96 -1.09 -2.21 -0.64 -1.14 -1.04 -1.36 -2.11 -1.45 -4.85 -3.45 -4.79 -5.42 -7.57 -8.11 -7.46 -7.2 -9.3 -3.52 -2.16
Ilośc akcji (mln) 0 1 12 22 32 39 41 42 42 42 50 62 74 84 86 91 101 109 115 118 122 125 129
Ważona ilośc akcji (mln) 0 1 12 22 32 39 41 42 42 42 50 62 74 84 86 91 101 109 115 118 122 125 129
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD